Results for the financial year ended on March 31, 2026
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Coral Laboratories Ltd reported audited standalone results for FY2026 ending March 31, 2026. Revenue from operations fell to Rs 8,589.97 lakhs from Rs 11,500.53 lakhs in FY2025, representing a 25.3% decline. Profit for the period dropped to Rs 1,638.13 lakhs from Rs 2,415.56 lakhs, a 32.2% decline year-over-year. EPS declined from Rs 67.61 to Rs 45.85. Operating margin compressed from 28.9% to 26.5%. The Board recommended a final dividend of 20% (Rs 2 per share). The statutory auditor issued an unmodified opinion. The company appointed new internal and cost auditors for FY2027. Capital expenditure increased significantly to Rs 2,353.18 lakhs (vs Rs 46.35 lakhs prior year), indicating major investments in PP&E.
The stock may face pressure due to significant revenue and profit decline. However, maintained dividend, strong cash flow from operations (Rs 1,561.54 lakhs), and heavy capex investments suggest the company is investing for recovery despite near-term headwinds.